A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
What You Need to Know Before You Apply
What is the purpose of this trial?
This study will collect biospecimens (including blood, tissue, and stool samples) and health information to create a database-a type of collection of information-for better understanding young onset colorectal cancer (YOCRC). The study will include both people with YOCRC and healthy people.
Who Is on the Research Team?
Andrea Cercek, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Sample Collection
Collection of biospecimens including blood, tissue, and stool samples from participants
Genomic Analysis
Perform whole exome sequencing, MSK-IMPACT DNA-methylation, and RNA assays of normal colonic mucosa and tumor
Follow-up
Participants are monitored for safety and effectiveness after sample collection and analysis
What Are the Treatments Tested in This Trial?
Interventions
- None
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor
Shaare Zedek Medical Center
Collaborator
Technion, Israel Institute of Technology
Collaborator